Comparison study of dual channel management policies of nationally negotiated drugs in Jiangsu province

Corresponding author: JIANG Rong, 13770643566@163.com

DOI: 10.12201/bmr.202209.00002

•  

  Abstract: Objective: Through systematically sorting out the implementation background and development history of dual channel management policy of national negotiated drugs, and the selection and management of drugs, selection of designated medical institutions and payment methods of medical insurance in Jiangsu Province and other cities, to provide references for the country to improve dual channel management policy. Methods: We searched the websites of Jiangsu Province and 13 municipal medical security bureaus to compare the policy documents and requirements of dual channel management, applied ROSTCM6 software to analyze the text of dual channel policies in Jiangsu Province and interviewed key interviewers for further analysis. Results: The results of the word frequency analysis showed that 6 keywords occurred more than 100 times while 2 keywords less than 10 times. The semantic network diagram shows that the core meaning of the dual channel policy is medical insurance; there are differences in the number of drug selection, selection criteria and procedures of designated medical institutions, payment treatment and other management in each region. Conclusions: Based on the practice of cities in Jiangsu Province, there are problems in the implementation of the dual-channel management policy, such as large differences in the number of designated medical institutions between regions, the lack of post-selection supervision requirements and measures for designated medical institutions, obvious differences in medical insurance payment treatment between municipals, and differences in management between regions affecting the settlement of some patients in different places etc., and it is suggested the designated medical institutions should be set reasonably, the dynamic management mechanism of designated retail pharmacy with “dual channel” should be formulated and improved, the role of universal commercial insurance should be brought into full play, and the management policy of off-site settlement should be improved.

  Key words: National negotiated drugs; Dual channel management; Dual channel drug selection; Designated medical institutions; Medical insurance payment

  Submit time: 1 September 2022

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Liu Mengjia, Zhang Jinsui, Chen Wen, Hu Min. The Importance and Realization Strategy of Credit Management of Designated Medical Institutions in the Supervision of Medical Insurance Fund. 2020. doi: 10.12201/bmr.202009.00017

  LYU Lan-ting. Research on the evolution and diffusion mechanism of drug negotiation policy in China*. 2022. doi: 10.12201/bmr.202210.00019

  Yang Haoyun, Zhang Xiao, Ding Chenyu. Optimized path design outpatient co-ordination system mechanism for employee medical insurance in Jiangsu Province based on SWOT analysis. 2022. doi: 10.12201/bmr.202204.00009

  LI Zhao, Zhao Ke, Zhou Lulin, Chen Sheng. Research on the Comparison and Development Countermeasures of Pharmaceutical Group Purchasing Modes from the Perspective of the Normalization of National Centralized Procurement. 2021. doi: 10.12201/bmr.202109.00037

  liutongxin, zhouliangrong, chenli, zhoupengxiang. Construction of credit evaluation index system for designated hospitals of medical insurance based on regulatory demand -- Taking zhangjiajie experimental study as an example. 2022. doi: 10.12201/bmr.202110.00003

  Sun Yan, Zhu Zheng, Yang Li. Influencing factors analysis on price reduction in national volume-based drug procurement.. 2022. doi: 10.12201/bmr.202203.00008

  xuguangjian, qiaoyukun. Research on the linkage mechanism between the adjustment of medical service price and the reform of medical insurance payment mode in China. 2021. doi: 10.12201/bmr.202104.00018

  CHEN Tong, JIANG Rong, SHAO Rong. Research and Enlightenment on Canadian Pharmaceutical Rebates Agreements. 2021. doi: 10.12201/bmr.202101.00019

  Li Hong-yu, Sun Qiang. Analysis of the impact of the Two Ballot System policy on drug supply in Shandong province. 2021. doi: 10.12201/bmr.202011.00015

  songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

• ID	Submit time	Number	Download
  1	2022-07-11	bmr.202209.00002V1	Download

• Public  Anonymous  To author only Submit Comments